Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innexus Biotechnology Inc (IXSBF)
OTHER OTC:IXSBF
Holding IXSBF?
Track your performance easily
IXSBF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.02
Previous Close$0.01
Volume5.00K
Average Volume (3M)N/A
Market Cap
$126.00
Enterprise Value$4.93M
Total Cash (Recent Filing)C$31.43K
Total Debt (Recent Filing)C$6.72M
Price to Earnings (P/E)―
Beta-67.97
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding163,201,977
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation51.77
R-Squared0.01
Alpha22.39
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
9.12%
Insiders
0.00% Mutual Funds
0.01% Other Institutional Investors
90.87% Public Companies and
Individual Investors
IXSBF FAQ
What was Innexus Biotechnology Inc’s price range in the past 12 months?
Innexus Biotechnology Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Innexus Biotechnology Inc’s market cap?
Currently, no data Available
When is Innexus Biotechnology Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Innexus Biotechnology Inc’s earnings last quarter?
Currently, no data Available
Is Innexus Biotechnology Inc overvalued?
According to Wall Street analysts Innexus Biotechnology Inc’s price is currently Overvalued.
Does Innexus Biotechnology Inc pay dividends?
Innexus Biotechnology Inc does not currently pay dividends.
What is Innexus Biotechnology Inc’s EPS estimate?
Innexus Biotechnology Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innexus Biotechnology Inc have?
Innexus Biotechnology Inc has 126,271,000 shares outstanding.
What happened to Innexus Biotechnology Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Innexus Biotechnology Inc?
Currently, no hedge funds are holding shares in IXSBF
---
Company Description
Innexus Biotechnology Inc
InNexus Biotechnology, Inc. develops commercial opportunities based on the field of monoclonal antibodies, naturally occurring proteins that fight infection and disease, utilizing its proprietary DXL and Transmab technologies in three focus areas: ophthalmology, dermatology and oncology. The company was founded by Alton Charles Morgan on September 5, 1997 and is headquartered in Vancouver, Canada.
---
Technical Analysis
Agenus
―
Northwest Biotherapeutics
―
Cyclacel Pharmaceuticals
―
TRACON Pharmaceuticals
―
---